CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 8-K Event Regulation FD disclosure
- 4 Option exercise Chief Commerical Officer acquired 208 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Commerical Officer bought 12,000 shares at $1.87 ($22,428)
- 4 Option exercise Chief Commerical Officer acquired 833 shares (option exercise)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 14,000 shares at $1.86 ($26,079)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change · Other events
- 424B4 Offering Prospectus
- FWP Offering Free Writing Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results
Page 8 of 46 · 907 filings